InvestorsHub Logo
Followers 8
Posts 1167
Boards Moderated 1
Alias Born 01/07/2008

Re: None

Tuesday, 01/19/2010 11:35:25 AM

Tuesday, January 19, 2010 11:35:25 AM

Post# of 18483
SAN DIEGO, Jan. 19 /PRNewswire-FirstCall/ --

Aethlon Medical, Inc. (OTC Bulletin Board: AEMD) announced today that its Chief Science Officer, Dr. Richard H. Tullis, will give a clinical presentation of the Aethlon Hemopurifier® at the 12th International Conference on Dialysis on January 22nd. The presentation will review treatment outcomes of dialysis patients infected with Hepatitis-C (HCV), and will discuss the additional use of the Hemopurifier® in HIV and Cancer care. The conference will be held at the Marriott New Orleans in New Orleans, Louisiana. Additional information, including the speaker agenda, can be accessed online at: http://www.renalresearch.com/

(Logo: http://www.newscom.com/cgi-bin/prnh/20090325/LA88762LOGO-b)

About Aethlon Medical

Aethlon Medical creates diagnostic and therapeutic device solutions for infectious disease and cancer. Our Hemopurifier® represents the first-in-class medical device to selectively adsorb viruses and immunosuppressive toxins from the bloodstream. The Hemopurifier® seeks to improve Hepatitis-C treatment outcomes and serves as a broad-spectrum treatment countermeasure against bioterror and pandemic threats. Additional information regarding Aethlon Medical can be accessed online at http://www.aethlonmedical.com/

Contacts:

RedChip Companies, Inc

Jon Cunningham 1-800-733-2447, Ext. 107

Jim Joyce Chairman, CEO 858.459.7800 x301
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AEMD News